R&D News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–12 of 44 articles
Adial Pharmaceuticals Completes Azora Merger, Expands Ulcerative Colitis Pipeline
Biotech’s coming of age: AI, capital efficiency and China reshape the field
Edgewise Therapeutics’ EDG-7500 clears key Phase 2 test
Celiac disease therapies enter a new era of innovation
Neumora navacaprant fails Phase 3 as EnGene cuts 50% of staff
Global hematology trials keep research patient-centered and regionally relevant
Hillhurst Bio doses first subject in Phase 2a HBI-002 Parkinson's trial
Planning a successful pivot from lab to clinic: a practical career map
HFMA conference: Affordability was the focus, but fixes remained unclear
FDA Clears First OTC CGM for Children: Dexcom Expands Stelo
FDA authorizes generic nitenpyram for New World screwworm in pets
HHS responds coolly to alcohol risk paper amid cancer-warning debate